Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database

scientific article published on April 2009

Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/597354
P932PMC publication ID2758295
P698PubMed publication ID19226231
P5875ResearchGate publication ID24024167

P50authorNagalingeswaran KumarasamyQ63142619
Yi-Ming Arthur ChenQ66739728
Somnuek SungkanuparphQ75156091
Praphan PhanuphakQ90051565
Sanjay PujariQ91153560
Fujie ZhangQ101133134
Rossana DitangcoQ114446763
Jun Yong ChoiQ40143606
Adeeba KamarulzamanQ55950718
P2093author name stringShinichi Oka
Saphonn Vonthanak
Matthew G Law
Man Po Lee
Christopher K C Lee
Jialun Zhou
Patrick C K Li
Poh Lian Lim
Thira Sirisanthana
Jeffery Smith
Preeyaporn Srasuebkul
Tuti P Merati
Goa Tau
P2860cites workA Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA StudyQ57877926
HIV disease progression in a patient cohort treated via a clinical research network in a resource limited settingQ58064891
Compliance with public sector HIV medical careQ72576293
Potential factors affecting adherence with HIV therapyQ73916433
Highly active antiretroviral treatment containing efavirenz or nevirapine and related toxicity in the TREAT Asia HIV Observational DatabaseQ79350864
Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational DatabaseQ79788120
Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West AfricaQ79914432
AIDS-defining illness diagnosed within 90 days after starting highly active antiretroviral therapy among patients from the TREAT Asia HIV Observational DatabaseQ80595030
CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV type 1 infection in untreated patientsQ82424050
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adultsQ28184343
Development and validation of a prognostic model for survival time data: application to prognosis of HIV positive patients treated with antiretroviral therapyQ30947115
The TREAT Asia HIV Observational Database: baseline and retrospective dataQ30981390
Prognostic model for HIV-1 disease progression in patients starting antiretroviral therapy was validated using independent dataQ31005220
Predictors of disease progression in HIV infection: a reviewQ35834337
Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD).Q36102478
Weight loss and body mass index as predictors of HIV disease progression to AIDS in adults. Aquitaine cohort, France, 1985-1997.Q36456768
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.Q37104874
Natural history of human immunodeficiency virus infection and key predictors of HIV disease progressionQ38216753
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errorsQ39605793
External validation is necessary in prediction research: a clinical exampleQ40549827
Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' OrganisationQ40936398
Survivor treatment selection bias in observational studies: examples from the AIDS literatureQ40983015
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study groupQ43656441
Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of MalawiQ43876514
Anemia and survival in human immunodeficiency virusQ43894912
More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell countsQ44939368
Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infectionQ44964641
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesQ46391119
Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patientsQ47601725
Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.Q50858852
Practical experiences on the necessity of external validation.Q51904901
Predicting short-term disease progression among HIV-infected patients in Asia and the Pacific region: preliminary results from the TREAT Asia HIV Observational Database (TAHOD).Q51974610
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score.Q53532256
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectdatabaseQ8513
HIVQ15787
anti-retroviral agentQ50430310
P304page(s)940-950
P577publication date2009-04-01
P1433published inClinical Infectious DiseasesQ5133764
P1476titleShort-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database
P478volume48

Reverse relations

cites work (P2860)
Q35852326Advanced HIV Disease at Enrolment in HIV Care: Trends and Associated Factors over a Ten Year Period in Cambodia
Q34813110An internationally generalizable risk index for mortality after one year of antiretroviral therapy.
Q34183235Anaemia in pregnancy is associated with advanced HIV disease
Q33986542Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia
Q40860723Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts
Q34056735Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa
Q26828045Nutrition assessment, counseling, and support interventions to improve health-related outcomes in people living with HIV/AIDS: a systematic review of the literature
Q37343891Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program
Q37028220Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database
Q42216147Prevalence and predictors of anaemia in patients with HIV infection at the initiation of combined antiretroviral therapy in Xinjiang, China
Q37168581Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings
Q58084945Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort
Q34556999Women experience a better long-term immune recovery and a better survival on HAART in Lao People's Democratic Republic

Search more.